CGEMCullinan Therapeutics, Inc.

$14.35+64% 1Y

Is the price fair?

What CGEM's price assumes

Price / book
1.20

Price / book · as of 2024-Q4

Details›
Price / bookas of 2024-Q4
1.20
Market capitalisation64.4 million shares, counted Jul 31, 2026
$923M

Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.

On our screens:Most shorted stocks